Simple brush test during endoscopy could spot esophageal cancer risk early

NCT ID NCT06523374

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study is testing whether cells collected by brushing the esophagus during a routine endoscopy can be genetically analyzed to better predict cancer risk in people with Barrett's esophagus. Researchers will collect brush samples, biopsies, and blood from 50 patients, then use advanced genetic techniques to see if they can tell high-risk from low-risk cases. The goal is to develop a more cost-effective surveillance strategy and eventually reduce unnecessary procedures while catching cancers earlier.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could lead to a simple brush test during endoscopy to better predict which Barrett's esophagus patients are at high risk for cancer, enabling more personalized surveillance.
What could go wrong
This is a very early pilot study with only 50 participants, focused on testing methods rather than proving a new treatment. The proposed risk model may not prove accurate enough in larger trials.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BARRETT'S ESOPHAGUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Adenocarcinoma Of Esophagus Barrett esophagus esophageal adenocarcinoma Esophageal Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • AZ Delta

    RECRUITING

    Roeselare, 8800, Belgium

  • CHU LILLE - Centre Hospitalier Universitaire de Lille

    RECRUITING

    Lille, 59000, France

  • IRCCS Ospedale San Raffaele

    RECRUITING

    Milan, Milano, 20132, Italy

  • Karolinska University Hospital

    RECRUITING

    Solna, SE-171 76, Sweden

  • Rigshospitalet

    RECRUITING

    Copenhagen, 2100, Denmark

  • Sint-Augustinus Hospital (ZAS)

    RECRUITING

    Wilrijk, Antwerpen, 2610, Belgium

  • St James's Hospital

    RECRUITING

    Dublin, D08 NHY1, Ireland

  • UZ Gent

    RECRUITING

    Ghent, 9000, Belgium

  • University Hospital Antwerp

    RECRUITING

    Edegem, Antwerpen, 2650, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.